TCF7L2 and colorectal carcinoma: Further, also complete independence of CRC cells from WNT/β-CATENIN pathway activity was reported18,19 which likewise would explain why a subset of human colorectal tumors and CRC cell lines can tolerate the loss of TCF7L2.